A study indicated that the simultaneous use of GPNA to block ASCT2, to inhibit the uptake of Gln by cancer cells, significantly enhanced the inhibitory effect of cetuximab on the proliferation of gastric cancer cells [170]. The gene discussed is SLC1A5; the disease is cancer.